Apollo Hospitals Enterprise Limited
APOLLOHOSP
주식 순위
#1777
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
주가
$83.93
시가총액
$12.07B
변동 (1일)
-1.23%
변동 (1년)
-7.79%
국가
IN
거래 Apollo Hospitals Enterprise Limited (APOLLOHOSP)
카테고리
Healthcare
Apollo Hospitals Enterprise Limited (APOLLOHOSP)의 수익
Jun 2026 기준 수익 TTM: $317.50M
Apollo Hospitals Enterprise Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $317.50M입니다. 2024년에 회사는 $165.56M의 수익을 올렸으며 이는 2023년의 수익 $133.91M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Apollo Hospitals Enterprise Limited의 수익 기록 (2005 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $317.50M | 33.17% |
| 2025 | $238.42M | 44.01% |
| 2024 | $165.56M | 23.63% |
| 2023 | $133.91M | -35.88% |
| 2022 | $208.85M | 590.24% |
| 2021 | $30.26M | -65.30% |
| 2020 | $87.21M | 62.14% |
| 2019 | $53.79M | 104.25% |
| 2018 | $26.33M | -23.10% |
| 2017 | $34.25M | -31.69% |
| 2016 | $50.13M | -32.69% |
| 2015 | $74.48M | -3.94% |
| 2014 | $77.54M | 3.33% |
| 2013 | $75.04M | 16.73% |
| 2012 | $64.29M | 9.63% |
| 2011 | $58.64M | 33.25% |
| 2010 | $44.01M | 66.26% |
| 2009 | $26.47M | -10.97% |
| 2008 | $29.73M | 5.27% |
| 2007 | $28.24M | 86.81% |
| 2006 | $15.12M | 25.12% |
| 2005 | $12.08M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $9.87B | 3,008.95% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,117.31% |
US
|
|
| $687.82M | 116.63% |
SA
|
|
| $1.25B | 292.66% |
BR
|
